1 hour ago
1
LD
- The FTC is investigating Hims & Hers Health (NYSE:HIMS) over some of its business practices, including whether the telemedicine company makes it too difficult to cancel subscriptions.
- Shares are down 5% in after-hours trading.
- While the probe itself was disclosed
English (US) ·